Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Medical Oncology
•
Internal Medicine
•
Thrombosis
•
Hematology
•
Hemostasis/Thrombosis
When do you consider indefinite anticoagulation in someone with first episode of calf vein DVT?
Related Questions
For patients with newly diagnosed VTE on IV heparin planned for transition to DOAC, would you start at the loading or maintenance DOAC dose?
Does your evaluation of a young person with spontaneous upper extremity DVT vary as compared to lower extremity DVT?
How do you manage anticoagulation in a patient with DVT from likely malignant mechanical obstruction?
Is there a role for DOAC use for patients with unprovoked PE, that have had recent sleeve gastrectomy with duodenal bypass?
How would you counsel a female to male transgender patient regarding VTE risk with testosterone therapy, who has additional mild-moderate risk factors for thrombosis?
What is your protocol for transitioning to oral anticoagulation post-thrombolysis for pulmonary embolism?
Would you evaluate for thrombophilia in patients with incidental splenic infarcts in the setting of known cirrhosis, portal hypertension, and splenomegaly?
Does a positive lupus anticoagulant alone confer high enough risk that warfarin is preferred over DOACs in antiphospholipid syndrome?
How do you start and manage therapeutic SC heparin for acute thrombosis in pregnancy as the patient approaches delivery?
How would you manage superficial vein thrombosis that persists on imaging after treatment with full dose anticoagulation?
